Thomas Jansson
Concepts (465)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placenta | 95 | 2026 | 786 | 17.980 |
Why?
| | Trophoblasts | 47 | 2026 | 218 | 11.120 |
Why?
| | TOR Serine-Threonine Kinases | 50 | 2026 | 454 | 9.040 |
Why?
| | Fetal Growth Retardation | 41 | 2025 | 593 | 8.550 |
Why?
| | Fetal Development | 32 | 2026 | 298 | 7.680 |
Why?
| | Maternal-Fetal Exchange | 24 | 2021 | 170 | 5.240 |
Why?
| | Pregnancy | 137 | 2026 | 7202 | 5.240 |
Why?
| | Amino Acids | 24 | 2026 | 519 | 5.130 |
Why?
| | Amino Acid Transport System A | 13 | 2025 | 37 | 4.460 |
Why?
| | Amino Acid Transport Systems | 16 | 2024 | 43 | 4.340 |
Why?
| | Diabetes, Gestational | 17 | 2023 | 306 | 4.170 |
Why?
| | Adiponectin | 15 | 2025 | 241 | 3.830 |
Why?
| | Insulin-Like Growth Factor Binding Protein 1 | 16 | 2023 | 25 | 3.320 |
Why?
| | Pregnancy Complications | 15 | 2024 | 602 | 3.090 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 17 | 2025 | 138 | 3.070 |
Why?
| | Insulin | 32 | 2026 | 2512 | 2.990 |
Why?
| | Insulin-Like Growth Factor I | 17 | 2026 | 317 | 2.850 |
Why?
| | Obesity | 24 | 2025 | 3116 | 2.700 |
Why?
| | Glucose Intolerance | 5 | 2022 | 142 | 2.580 |
Why?
| | Signal Transduction | 48 | 2026 | 5216 | 2.580 |
Why?
| | Maternal Nutritional Physiological Phenomena | 12 | 2024 | 178 | 2.500 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 9 | 2023 | 62 | 2.290 |
Why?
| | Folic Acid | 8 | 2025 | 198 | 2.250 |
Why?
| | Fetal Macrosomia | 11 | 2023 | 63 | 2.170 |
Why?
| | Amino Acid Transport System L | 7 | 2025 | 19 | 2.140 |
Why?
| | Birth Weight | 14 | 2021 | 514 | 2.000 |
Why?
| | Biological Transport | 20 | 2025 | 424 | 1.930 |
Why?
| | Papio | 14 | 2021 | 70 | 1.880 |
Why?
| | Prenatal Exposure Delayed Effects | 10 | 2024 | 652 | 1.820 |
Why?
| | Pregnancy Proteins | 6 | 2022 | 36 | 1.790 |
Why?
| | Female | 142 | 2026 | 78845 | 1.780 |
Why?
| | Fetus | 16 | 2024 | 804 | 1.670 |
Why?
| | Placental Insufficiency | 5 | 2019 | 126 | 1.640 |
Why?
| | Folate Receptor 1 | 4 | 2019 | 17 | 1.520 |
Why?
| | Decidua | 7 | 2022 | 22 | 1.490 |
Why?
| | Fusion Regulatory Protein 1, Light Chains | 3 | 2026 | 9 | 1.460 |
Why?
| | Fetal Weight | 7 | 2021 | 53 | 1.450 |
Why?
| | Cell Membrane | 11 | 2020 | 707 | 1.450 |
Why?
| | Animals | 69 | 2026 | 38030 | 1.410 |
Why?
| | Multiprotein Complexes | 7 | 2025 | 172 | 1.400 |
Why?
| | Placentation | 6 | 2021 | 52 | 1.390 |
Why?
| | Insulin Resistance | 10 | 2024 | 1244 | 1.370 |
Why?
| | Receptors, Adiponectin | 5 | 2025 | 22 | 1.360 |
Why?
| | Glucose Transporter Type 1 | 5 | 2020 | 48 | 1.250 |
Why?
| | Fetal Blood | 5 | 2025 | 327 | 1.240 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 3 | 2026 | 17 | 1.200 |
Why?
| | Down-Regulation | 8 | 2020 | 618 | 1.190 |
Why?
| | Folic Acid Deficiency | 3 | 2021 | 49 | 1.170 |
Why?
| | Liver | 7 | 2026 | 1896 | 1.150 |
Why?
| | Extracellular Vesicles | 2 | 2022 | 171 | 1.130 |
Why?
| | Fetal Nutrition Disorders | 3 | 2015 | 7 | 1.120 |
Why?
| | Phosphorylation | 23 | 2023 | 1707 | 1.080 |
Why?
| | Pregnancy Trimester, First | 7 | 2021 | 139 | 1.050 |
Why?
| | Cells, Cultured | 23 | 2025 | 4148 | 1.040 |
Why?
| | Heart Diseases | 2 | 2022 | 341 | 1.030 |
Why?
| | Cardiomegaly | 2 | 2025 | 174 | 1.000 |
Why?
| | Blood Glucose | 7 | 2023 | 2341 | 0.990 |
Why?
| | Adiposity | 5 | 2026 | 532 | 0.990 |
Why?
| | Fatty Liver | 2 | 2022 | 253 | 0.980 |
Why?
| | Humans | 111 | 2026 | 145475 | 0.970 |
Why?
| | Diet, Protein-Restricted | 2 | 2021 | 11 | 0.940 |
Why?
| | Leucine | 7 | 2021 | 116 | 0.910 |
Why?
| | Intracellular Signaling Peptides and Proteins | 6 | 2025 | 456 | 0.910 |
Why?
| | Transposases | 1 | 2025 | 18 | 0.900 |
Why?
| | Pregnancy Trimesters | 1 | 2025 | 20 | 0.890 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2021 | 910 | 0.880 |
Why?
| | Mice | 24 | 2026 | 18329 | 0.870 |
Why?
| | Gestational Age | 14 | 2021 | 987 | 0.850 |
Why?
| | Docosahexaenoic Acids | 6 | 2024 | 88 | 0.840 |
Why?
| | Body Mass Index | 13 | 2024 | 2445 | 0.800 |
Why?
| | Transcriptome | 4 | 2022 | 1038 | 0.800 |
Why?
| | Reduced Folate Carrier Protein | 3 | 2019 | 9 | 0.790 |
Why?
| | Lipid Metabolism | 7 | 2024 | 529 | 0.790 |
Why?
| | Symporters | 1 | 2023 | 48 | 0.790 |
Why?
| | Pregnancy, Animal | 3 | 2014 | 51 | 0.780 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 2 | 2021 | 10 | 0.770 |
Why?
| | Infant, Newborn | 21 | 2023 | 6447 | 0.750 |
Why?
| | Caloric Restriction | 2 | 2015 | 133 | 0.740 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2023 | 143 | 0.730 |
Why?
| | Overnutrition | 1 | 2022 | 28 | 0.710 |
Why?
| | Glucose Transport Proteins, Facilitative | 2 | 2014 | 16 | 0.680 |
Why?
| | Adult | 45 | 2026 | 40777 | 0.680 |
Why?
| | Case-Control Studies | 8 | 2025 | 3623 | 0.670 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2021 | 17 | 0.660 |
Why?
| | Glucose | 11 | 2022 | 1048 | 0.660 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 39 | 0.660 |
Why?
| | Myocytes, Cardiac | 1 | 2025 | 546 | 0.660 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 3 | 2021 | 264 | 0.650 |
Why?
| | N-Acetylglucosaminyltransferases | 1 | 2020 | 24 | 0.650 |
Why?
| | Pregnancy Trimester, Second | 2 | 2020 | 83 | 0.650 |
Why?
| | Fatty Acid Transport Proteins | 4 | 2018 | 22 | 0.640 |
Why?
| | Membrane Transport Proteins | 3 | 2023 | 154 | 0.640 |
Why?
| | Serotonin | 2 | 2020 | 297 | 0.630 |
Why?
| | Food Deprivation | 3 | 2020 | 28 | 0.620 |
Why?
| | cdc42 GTP-Binding Protein | 1 | 2020 | 21 | 0.620 |
Why?
| | Leptin | 4 | 2015 | 248 | 0.610 |
Why?
| | Overweight | 3 | 2017 | 614 | 0.610 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2020 | 56 | 0.610 |
Why?
| | DNA Methylation | 3 | 2023 | 674 | 0.600 |
Why?
| | AMP-Activated Protein Kinases | 6 | 2022 | 192 | 0.590 |
Why?
| | Phospholipids | 4 | 2024 | 214 | 0.590 |
Why?
| | Apelin | 1 | 2019 | 10 | 0.580 |
Why?
| | Maternal Exposure | 2 | 2018 | 189 | 0.580 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 2 | 2015 | 46 | 0.570 |
Why?
| | Mice, Inbred C57BL | 11 | 2024 | 5983 | 0.560 |
Why?
| | Protein Kinases | 4 | 2019 | 312 | 0.560 |
Why?
| | PPAR gamma | 5 | 2022 | 178 | 0.550 |
Why?
| | Adaptor Proteins, Signal Transducing | 5 | 2015 | 425 | 0.540 |
Why?
| | Fatty Acid-Binding Proteins | 4 | 2018 | 79 | 0.540 |
Why?
| | Gene Knockdown Techniques | 6 | 2025 | 333 | 0.540 |
Why?
| | Regulatory-Associated Protein of mTOR | 6 | 2019 | 24 | 0.540 |
Why?
| | Phthalic Acids | 1 | 2018 | 42 | 0.540 |
Why?
| | Endocrine Disruptors | 1 | 2018 | 41 | 0.530 |
Why?
| | Infant, Premature | 2 | 2022 | 619 | 0.520 |
Why?
| | Fatty Acids, Unsaturated | 4 | 2018 | 96 | 0.520 |
Why?
| | Mice, Obese | 4 | 2022 | 68 | 0.520 |
Why?
| | Casein Kinase II | 7 | 2021 | 22 | 0.520 |
Why?
| | Glucocorticoids | 2 | 2019 | 531 | 0.520 |
Why?
| | Metabolic Diseases | 1 | 2018 | 114 | 0.510 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2015 | 192 | 0.510 |
Why?
| | Primary Cell Culture | 7 | 2019 | 172 | 0.510 |
Why?
| | RNA Interference | 5 | 2021 | 475 | 0.500 |
Why?
| | Organ Size | 8 | 2021 | 461 | 0.500 |
Why?
| | Proteome | 2 | 2019 | 514 | 0.500 |
Why?
| | Specimen Handling | 1 | 2018 | 182 | 0.500 |
Why?
| | Microvilli | 5 | 2019 | 75 | 0.480 |
Why?
| | Hormones | 2 | 2008 | 135 | 0.460 |
Why?
| | Homeostasis | 1 | 2020 | 642 | 0.460 |
Why?
| | Disease Models, Animal | 9 | 2022 | 4560 | 0.460 |
Why?
| | Chorionic Villi | 4 | 2019 | 25 | 0.460 |
Why?
| | Gene Expression Regulation | 6 | 2021 | 2597 | 0.450 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 5 | 2015 | 55 | 0.450 |
Why?
| | Altitude | 1 | 2019 | 463 | 0.450 |
Why?
| | RNA, Small Interfering | 6 | 2023 | 637 | 0.430 |
Why?
| | Diet, High-Fat | 5 | 2024 | 266 | 0.430 |
Why?
| | Up-Regulation | 4 | 2025 | 847 | 0.420 |
Why?
| | Rapamycin-Insensitive Companion of mTOR Protein | 5 | 2019 | 27 | 0.420 |
Why?
| | Rats | 12 | 2025 | 5584 | 0.420 |
Why?
| | Homocysteine | 2 | 2017 | 152 | 0.410 |
Why?
| | Weight Gain | 2 | 2015 | 561 | 0.400 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2013 | 32 | 0.400 |
Why?
| | Ubiquitination | 3 | 2022 | 118 | 0.390 |
Why?
| | Vitamin D | 1 | 2016 | 403 | 0.380 |
Why?
| | Nutritional Status | 1 | 2015 | 353 | 0.380 |
Why?
| | Proton-Coupled Folate Transporter | 3 | 2019 | 9 | 0.370 |
Why?
| | Dietary Supplements | 4 | 2024 | 583 | 0.360 |
Why?
| | Placental Circulation | 6 | 2019 | 71 | 0.360 |
Why?
| | Male | 27 | 2026 | 72843 | 0.360 |
Why?
| | Animals, Newborn | 3 | 2025 | 891 | 0.360 |
Why?
| | Fatty Acids | 5 | 2022 | 457 | 0.360 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 3 | 2016 | 15 | 0.350 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2022 | 440 | 0.350 |
Why?
| | Pregnancy in Diabetics | 3 | 2021 | 123 | 0.350 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 2187 | 0.350 |
Why?
| | PPAR alpha | 4 | 2015 | 55 | 0.320 |
Why?
| | STAT3 Transcription Factor | 2 | 2014 | 206 | 0.310 |
Why?
| | Biological Availability | 2 | 2023 | 145 | 0.310 |
Why?
| | Rats, Wistar | 9 | 2021 | 450 | 0.310 |
Why?
| | Oleic Acid | 3 | 2014 | 40 | 0.310 |
Why?
| | Dietary Proteins | 1 | 2011 | 135 | 0.300 |
Why?
| | Dietary Fats | 2 | 2008 | 308 | 0.300 |
Why?
| | Ion Transport | 1 | 2009 | 62 | 0.300 |
Why?
| | Cohort Studies | 6 | 2023 | 6013 | 0.300 |
Why?
| | Carrier Proteins | 5 | 2021 | 728 | 0.300 |
Why?
| | Biomarkers | 6 | 2024 | 4295 | 0.290 |
Why?
| | Hypoxia | 3 | 2022 | 1199 | 0.280 |
Why?
| | Rats, Sprague-Dawley | 4 | 2025 | 2524 | 0.280 |
Why?
| | In Vitro Techniques | 5 | 2021 | 1048 | 0.280 |
Why?
| | beta-Alanine | 2 | 2006 | 25 | 0.270 |
Why?
| | Proteolysis | 2 | 2022 | 172 | 0.270 |
Why?
| | RNA, Messenger | 6 | 2024 | 2803 | 0.270 |
Why?
| | Exosomes | 2 | 2019 | 104 | 0.260 |
Why?
| | Food | 1 | 2009 | 150 | 0.260 |
Why?
| | Amino Acid Transport Systems, Neutral | 1 | 2007 | 4 | 0.260 |
Why?
| | Malaria, Falciparum | 2 | 2017 | 32 | 0.250 |
Why?
| | Endoplasmic Reticulum Stress | 2 | 2020 | 118 | 0.250 |
Why?
| | Choline | 2 | 2024 | 137 | 0.250 |
Why?
| | Testosterone | 3 | 2016 | 416 | 0.250 |
Why?
| | Taurine | 1 | 2007 | 41 | 0.240 |
Why?
| | Young Adult | 10 | 2024 | 14219 | 0.240 |
Why?
| | Protein Transport | 3 | 2021 | 442 | 0.240 |
Why?
| | Biological Transport, Active | 3 | 2015 | 69 | 0.240 |
Why?
| | Hyperglycemia | 2 | 2007 | 379 | 0.240 |
Why?
| | MicroRNAs | 2 | 2025 | 686 | 0.240 |
Why?
| | CD36 Antigens | 2 | 2016 | 32 | 0.230 |
Why?
| | Atrial Natriuretic Factor | 1 | 2025 | 55 | 0.230 |
Why?
| | Adult Children | 2 | 2024 | 27 | 0.230 |
Why?
| | Mitochondria | 2 | 2025 | 992 | 0.230 |
Why?
| | Hep G2 Cells | 7 | 2021 | 73 | 0.230 |
Why?
| | Cardiac Myosins | 1 | 2025 | 37 | 0.230 |
Why?
| | Ventricular Myosins | 1 | 2025 | 39 | 0.230 |
Why?
| | Cesarean Section | 2 | 2022 | 230 | 0.230 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2025 | 109 | 0.220 |
Why?
| | Energy Intake | 1 | 2008 | 512 | 0.220 |
Why?
| | Chromatography, Liquid | 2 | 2023 | 450 | 0.220 |
Why?
| | Palmitic Acid | 2 | 2014 | 40 | 0.210 |
Why?
| | Cell Hypoxia | 3 | 2021 | 247 | 0.210 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2004 | 56 | 0.210 |
Why?
| | Hypoglycemic Agents | 3 | 2019 | 1399 | 0.210 |
Why?
| | Myosin Heavy Chains | 1 | 2025 | 183 | 0.210 |
Why?
| | Protein Kinase C-alpha | 2 | 2021 | 37 | 0.210 |
Why?
| | Maternal Age | 3 | 2021 | 128 | 0.200 |
Why?
| | Gene Silencing | 4 | 2021 | 202 | 0.200 |
Why?
| | Amino Acids, Essential | 1 | 2023 | 13 | 0.200 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 2 | 2022 | 125 | 0.200 |
Why?
| | Tandem Mass Spectrometry | 2 | 2023 | 572 | 0.200 |
Why?
| | Term Birth | 2 | 2015 | 25 | 0.200 |
Why?
| | Mice, Transgenic | 2 | 2025 | 2188 | 0.190 |
Why?
| | Embryonic Development | 2 | 2021 | 125 | 0.190 |
Why?
| | Umbilical Veins | 2 | 2014 | 58 | 0.190 |
Why?
| | Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 17 | 0.190 |
Why?
| | Oxidative Phosphorylation | 2 | 2025 | 209 | 0.180 |
Why?
| | Body Weight | 3 | 2012 | 971 | 0.180 |
Why?
| | 3T3-L1 Cells | 1 | 2022 | 36 | 0.180 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2023 | 149 | 0.170 |
Why?
| | Carnitine | 1 | 2022 | 91 | 0.170 |
Why?
| | Inflammation Mediators | 2 | 2015 | 506 | 0.170 |
Why?
| | Fetal Heart | 1 | 2022 | 56 | 0.170 |
Why?
| | Inflammation | 3 | 2026 | 2878 | 0.170 |
Why?
| | Sirolimus | 5 | 2020 | 280 | 0.170 |
Why?
| | Glucose Tolerance Test | 1 | 2022 | 360 | 0.170 |
Why?
| | MAP Kinase Signaling System | 3 | 2019 | 307 | 0.170 |
Why?
| | Monoamine Oxidase | 1 | 2020 | 27 | 0.160 |
Why?
| | Child, Preschool | 5 | 2026 | 11853 | 0.160 |
Why?
| | Intra-Abdominal Fat | 1 | 2022 | 101 | 0.160 |
Why?
| | Infant, Low Birth Weight | 2 | 2019 | 156 | 0.160 |
Why?
| | Triglycerides | 4 | 2023 | 520 | 0.160 |
Why?
| | Vitrification | 1 | 2020 | 7 | 0.160 |
Why?
| | Birth Rate | 1 | 2020 | 31 | 0.160 |
Why?
| | Organogenesis | 1 | 2021 | 63 | 0.160 |
Why?
| | Blastocyst | 1 | 2020 | 50 | 0.160 |
Why?
| | Embryo Implantation | 1 | 2020 | 34 | 0.160 |
Why?
| | Umbilical Cord | 1 | 2020 | 93 | 0.160 |
Why?
| | Embryo, Mammalian | 1 | 2021 | 234 | 0.160 |
Why?
| | Skinfold Thickness | 1 | 2020 | 43 | 0.160 |
Why?
| | Embryo Transfer | 1 | 2020 | 45 | 0.160 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2022 | 382 | 0.160 |
Why?
| | Adipocytes | 1 | 2022 | 223 | 0.150 |
Why?
| | Cell Culture Techniques | 2 | 2021 | 372 | 0.150 |
Why?
| | Infant | 4 | 2024 | 10077 | 0.150 |
Why?
| | Adipose Tissue | 2 | 2019 | 645 | 0.150 |
Why?
| | Receptor, Insulin | 1 | 2019 | 93 | 0.150 |
Why?
| | Apelin Receptors | 1 | 2019 | 4 | 0.150 |
Why?
| | Myometrium | 1 | 2019 | 38 | 0.150 |
Why?
| | Immunohistochemistry | 3 | 2018 | 1716 | 0.150 |
Why?
| | Enzyme Activation | 3 | 2015 | 762 | 0.150 |
Why?
| | Organelle Biogenesis | 1 | 2019 | 14 | 0.150 |
Why?
| | Protein Kinase C | 2 | 2021 | 251 | 0.140 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2019 | 55 | 0.140 |
Why?
| | Pediatric Obesity | 2 | 2024 | 638 | 0.140 |
Why?
| | Lysophosphatidylcholines | 1 | 2018 | 23 | 0.140 |
Why?
| | Myoblasts, Skeletal | 1 | 2018 | 12 | 0.140 |
Why?
| | Olive Oil | 1 | 2018 | 3 | 0.140 |
Why?
| | Electron Transport | 1 | 2019 | 110 | 0.140 |
Why?
| | Protein Interaction Maps | 1 | 2018 | 51 | 0.140 |
Why?
| | PPAR delta | 1 | 2018 | 6 | 0.140 |
Why?
| | Metabolomics | 1 | 2024 | 732 | 0.140 |
Why?
| | Tetrahydrofolates | 1 | 2018 | 16 | 0.140 |
Why?
| | Receptors, Glucocorticoid | 1 | 2019 | 129 | 0.140 |
Why?
| | Models, Biological | 4 | 2021 | 1764 | 0.140 |
Why?
| | Piperidines | 1 | 2019 | 222 | 0.130 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2017 | 32 | 0.130 |
Why?
| | alpha-Linolenic Acid | 1 | 2017 | 8 | 0.130 |
Why?
| | Glyburide | 1 | 2017 | 31 | 0.130 |
Why?
| | Child | 6 | 2024 | 22707 | 0.130 |
Why?
| | Blood Platelets | 1 | 2020 | 379 | 0.130 |
Why?
| | Mice, Inbred ICR | 1 | 2017 | 113 | 0.130 |
Why?
| | Arachidonic Acid | 1 | 2017 | 102 | 0.130 |
Why?
| | Lipids | 1 | 2022 | 707 | 0.130 |
Why?
| | Time Factors | 2 | 2025 | 7123 | 0.130 |
Why?
| | Pregnancy Complications, Parasitic | 1 | 2017 | 9 | 0.130 |
Why?
| | Phosphoproteins | 2 | 2011 | 337 | 0.120 |
Why?
| | Protein Processing, Post-Translational | 3 | 2015 | 471 | 0.120 |
Why?
| | Muscle Contraction | 1 | 2019 | 429 | 0.120 |
Why?
| | Receptors, Calcitriol | 1 | 2016 | 55 | 0.120 |
Why?
| | Electroacupuncture | 1 | 2016 | 2 | 0.120 |
Why?
| | Cholecalciferol | 1 | 2016 | 61 | 0.120 |
Why?
| | Prenatal Diagnosis | 1 | 2018 | 196 | 0.120 |
Why?
| | Coenzyme A Ligases | 1 | 2016 | 15 | 0.120 |
Why?
| | Amino Acid Transport System y+L | 1 | 2015 | 4 | 0.120 |
Why?
| | Resource Allocation | 1 | 2016 | 52 | 0.120 |
Why?
| | Caspase 3 | 2 | 2014 | 242 | 0.120 |
Why?
| | Echocardiography | 1 | 2019 | 647 | 0.120 |
Why?
| | Fatty Acid Binding Protein 3 | 1 | 2015 | 6 | 0.120 |
Why?
| | Obstetrics | 1 | 2018 | 177 | 0.120 |
Why?
| | Animal Nutritional Physiological Phenomena | 1 | 2015 | 12 | 0.120 |
Why?
| | Androgens | 1 | 2017 | 181 | 0.120 |
Why?
| | Excitatory Amino Acids | 1 | 2015 | 7 | 0.110 |
Why?
| | Prospective Studies | 2 | 2021 | 8057 | 0.110 |
Why?
| | Gynecology | 1 | 2018 | 181 | 0.110 |
Why?
| | Transport Vesicles | 1 | 2015 | 22 | 0.110 |
Why?
| | Dietary Sucrose | 1 | 2015 | 50 | 0.110 |
Why?
| | Diet | 3 | 2022 | 1277 | 0.110 |
Why?
| | Proteomics | 1 | 2022 | 1188 | 0.110 |
Why?
| | Hepatocytes | 2 | 2014 | 224 | 0.110 |
Why?
| | Anti-Inflammatory Agents | 1 | 2019 | 477 | 0.110 |
Why?
| | Heart | 1 | 2019 | 626 | 0.110 |
Why?
| | Lipase | 1 | 2015 | 75 | 0.110 |
Why?
| | Autophagy | 1 | 2017 | 291 | 0.110 |
Why?
| | Interleukin-1beta | 2 | 2014 | 389 | 0.110 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2015 | 155 | 0.110 |
Why?
| | Amygdala | 1 | 2015 | 199 | 0.100 |
Why?
| | Analysis of Variance | 2 | 2017 | 1300 | 0.100 |
Why?
| | Myocardium | 1 | 2019 | 934 | 0.100 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2017 | 372 | 0.100 |
Why?
| | bcl-2-Associated X Protein | 1 | 2013 | 53 | 0.100 |
Why?
| | Environmental Exposure | 1 | 2018 | 578 | 0.100 |
Why?
| | Transfection | 1 | 2015 | 926 | 0.100 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2013 | 29 | 0.100 |
Why?
| | Receptor, IGF Type 1 | 3 | 2021 | 64 | 0.100 |
Why?
| | Prognosis | 2 | 2019 | 4316 | 0.100 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2021 | 2588 | 0.100 |
Why?
| | Ceramides | 1 | 2014 | 117 | 0.100 |
Why?
| | Epigenesis, Genetic | 1 | 2018 | 679 | 0.100 |
Why?
| | Ovarian Neoplasms | 1 | 2019 | 595 | 0.100 |
Why?
| | Apoptosis | 2 | 2019 | 2440 | 0.100 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2017 | 440 | 0.090 |
Why?
| | Blood Urea Nitrogen | 1 | 2012 | 53 | 0.090 |
Why?
| | Protein Subunits | 1 | 2013 | 229 | 0.090 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2953 | 0.090 |
Why?
| | Hyperandrogenism | 1 | 2012 | 25 | 0.090 |
Why?
| | Behavior, Animal | 1 | 2015 | 519 | 0.090 |
Why?
| | Energy Metabolism | 2 | 2015 | 935 | 0.090 |
Why?
| | Muscle, Skeletal | 1 | 2022 | 1789 | 0.090 |
Why?
| | Oxygen | 1 | 2017 | 978 | 0.090 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2011 | 26 | 0.080 |
Why?
| | Brain | 1 | 2023 | 2947 | 0.080 |
Why?
| | Liver Neoplasms | 1 | 2017 | 776 | 0.080 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2012 | 154 | 0.080 |
Why?
| | Phosphatidylcholines | 2 | 2023 | 130 | 0.080 |
Why?
| | Biomedical Research | 1 | 2017 | 717 | 0.080 |
Why?
| | Colorado | 1 | 2020 | 4554 | 0.080 |
Why?
| | Mass Screening | 1 | 2018 | 1360 | 0.070 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2018 | 1419 | 0.070 |
Why?
| | Mothers | 1 | 2015 | 765 | 0.070 |
Why?
| | Stromal Cells | 2 | 2021 | 121 | 0.070 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1371 | 0.070 |
Why?
| | Microscopy, Fluorescence | 2 | 2021 | 408 | 0.070 |
Why?
| | Cross-Sectional Studies | 4 | 2022 | 5905 | 0.070 |
Why?
| | Immunity, Innate | 1 | 2014 | 835 | 0.070 |
Why?
| | Anxiety | 1 | 2015 | 1118 | 0.070 |
Why?
| | Pregnancy Trimester, Third | 1 | 2008 | 119 | 0.070 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenases | 1 | 2007 | 3 | 0.070 |
Why?
| | Sex Factors | 1 | 2013 | 2105 | 0.060 |
Why?
| | Glucose Transporter Type 3 | 1 | 2007 | 15 | 0.060 |
Why?
| | Amino Acid Transport System y+ | 1 | 2007 | 9 | 0.060 |
Why?
| | Hyperlipoproteinemia Type I | 1 | 2007 | 7 | 0.060 |
Why?
| | Fluorescent Antibody Technique | 2 | 2018 | 365 | 0.060 |
Why?
| | Uterus | 2 | 2019 | 227 | 0.060 |
Why?
| | Lipoprotein Lipase | 1 | 2007 | 56 | 0.060 |
Why?
| | Oxidative Stress | 2 | 2018 | 1356 | 0.060 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2006 | 21 | 0.060 |
Why?
| | Sex Characteristics | 2 | 2023 | 782 | 0.060 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2018 | 199 | 0.060 |
Why?
| | Glucose Clamp Technique | 1 | 2007 | 199 | 0.060 |
Why?
| | Folic Acid Transporters | 1 | 2025 | 3 | 0.060 |
Why?
| | Cell Respiration | 1 | 2025 | 105 | 0.060 |
Why?
| | Mass Spectrometry | 2 | 2021 | 730 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3413 | 0.060 |
Why?
| | Lentivirus | 1 | 2025 | 61 | 0.050 |
Why?
| | Lactic Acid | 1 | 2006 | 295 | 0.050 |
Why?
| | Osmolar Concentration | 1 | 2004 | 168 | 0.050 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2004 | 196 | 0.050 |
Why?
| | Ephrin-A3 | 1 | 2024 | 1 | 0.050 |
Why?
| | Ephrins | 1 | 2024 | 8 | 0.050 |
Why?
| | Interviews as Topic | 1 | 2008 | 910 | 0.050 |
Why?
| | Microscopy, Electron | 1 | 2004 | 414 | 0.050 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2017 | 187 | 0.050 |
Why?
| | Ether | 1 | 2023 | 8 | 0.050 |
Why?
| | Ethyl Ethers | 1 | 2023 | 5 | 0.050 |
Why?
| | Plasmalogens | 1 | 2023 | 7 | 0.050 |
Why?
| | Ethers | 1 | 2023 | 19 | 0.050 |
Why?
| | Lipocalin-2 | 1 | 2024 | 80 | 0.050 |
Why?
| | Connexins | 1 | 2024 | 54 | 0.050 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 2 | 2014 | 153 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2023 | 76 | 0.050 |
Why?
| | Electrolytes | 1 | 2003 | 54 | 0.050 |
Why?
| | Receptors, Androgen | 2 | 2015 | 148 | 0.050 |
Why?
| | Cell Cycle Proteins | 1 | 2007 | 630 | 0.050 |
Why?
| | Body Composition | 1 | 2007 | 693 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 2028 | 0.050 |
Why?
| | Pregnancy, High-Risk | 1 | 2002 | 13 | 0.050 |
Why?
| | Interleukin-6 | 1 | 2006 | 776 | 0.040 |
Why?
| | Insulin, Regular, Human | 1 | 2022 | 47 | 0.040 |
Why?
| | Insulin Receptor Substrate Proteins | 2 | 2013 | 55 | 0.040 |
Why?
| | Maleimides | 1 | 2021 | 21 | 0.040 |
Why?
| | Cell Shape | 1 | 2021 | 56 | 0.040 |
Why?
| | Receptors, Erythropoietin | 1 | 2021 | 21 | 0.040 |
Why?
| | Norway | 1 | 2021 | 41 | 0.040 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2021 | 149 | 0.040 |
Why?
| | Esterification | 1 | 2020 | 9 | 0.040 |
Why?
| | Cholesterol | 1 | 2023 | 408 | 0.040 |
Why?
| | Parity | 1 | 2021 | 111 | 0.040 |
Why?
| | Metabolome | 1 | 2024 | 388 | 0.040 |
Why?
| | Reference Values | 1 | 2002 | 798 | 0.040 |
Why?
| | Epithelial Cells | 1 | 2007 | 1131 | 0.040 |
Why?
| | Erythropoietin | 1 | 2021 | 100 | 0.040 |
Why?
| | Receptors, Amino Acid | 1 | 2020 | 25 | 0.040 |
Why?
| | NF-kappa B | 2 | 2014 | 666 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 848 | 0.040 |
Why?
| | Neoplasms, Cystic, Mucinous, and Serous | 1 | 2019 | 27 | 0.040 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 296 | 0.040 |
Why?
| | Adenosine Triphosphatases | 1 | 2020 | 159 | 0.040 |
Why?
| | Cell Cycle Checkpoints | 1 | 2019 | 97 | 0.040 |
Why?
| | Sodium | 1 | 2020 | 198 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 174 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2021 | 552 | 0.040 |
Why?
| | Arachidonic Acids | 1 | 2018 | 42 | 0.040 |
Why?
| | Erythrocytes | 1 | 2024 | 748 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2019 | 310 | 0.030 |
Why?
| | Mitosis | 1 | 2019 | 193 | 0.030 |
Why?
| | Perilipin-2 | 1 | 2018 | 40 | 0.030 |
Why?
| | Environmental Health | 1 | 2018 | 40 | 0.030 |
Why?
| | Hippocampus | 1 | 2024 | 971 | 0.030 |
Why?
| | Adolescent | 3 | 2019 | 22530 | 0.030 |
Why?
| | Phagosomes | 1 | 2017 | 40 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2024 | 874 | 0.030 |
Why?
| | Indoles | 1 | 2021 | 507 | 0.030 |
Why?
| | Lysosomes | 1 | 2017 | 131 | 0.030 |
Why?
| | Sheep | 1 | 2020 | 876 | 0.030 |
Why?
| | Lipogenesis | 1 | 2017 | 62 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1067 | 0.030 |
Why?
| | Phosphoserine | 1 | 2015 | 25 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2019 | 1547 | 0.030 |
Why?
| | Blotting, Western | 2 | 2010 | 1179 | 0.030 |
Why?
| | Lipid Peroxidation | 1 | 2015 | 167 | 0.030 |
Why?
| | Corticosterone | 1 | 2016 | 241 | 0.030 |
Why?
| | Adenylate Kinase | 1 | 2014 | 26 | 0.030 |
Why?
| | Caspase 10 | 1 | 2014 | 5 | 0.030 |
Why?
| | Chorionic Gonadotropin | 1 | 2014 | 78 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 959 | 0.030 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2014 | 110 | 0.030 |
Why?
| | GRB2 Adaptor Protein | 1 | 2013 | 12 | 0.020 |
Why?
| | Oxidoreductases | 1 | 2014 | 91 | 0.020 |
Why?
| | Transcription Factors | 1 | 2021 | 1734 | 0.020 |
Why?
| | Transgenes | 1 | 2014 | 190 | 0.020 |
Why?
| | Estradiol Dehydrogenases | 1 | 2012 | 1 | 0.020 |
Why?
| | Incidence | 1 | 2019 | 2923 | 0.020 |
Why?
| | Estrous Cycle | 1 | 2012 | 22 | 0.020 |
Why?
| | Metabolic Networks and Pathways | 1 | 2013 | 174 | 0.020 |
Why?
| | Binding Sites | 1 | 2015 | 1310 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2129 | 0.020 |
Why?
| | Random Allocation | 1 | 2012 | 365 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2019 | 2507 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2883 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3542 | 0.020 |
Why?
| | Dexamethasone | 1 | 2013 | 365 | 0.020 |
Why?
| | Toll-Like Receptor 4 | 1 | 2012 | 276 | 0.020 |
Why?
| | Attitude of Health Personnel | 1 | 2018 | 1193 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2012 | 401 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1100 | 0.020 |
Why?
| | Blood Pressure | 1 | 2016 | 1779 | 0.020 |
Why?
| | Gene Expression | 1 | 2013 | 1476 | 0.020 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2007 | 29 | 0.020 |
Why?
| | Middle Aged | 2 | 2019 | 36215 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1041 | 0.020 |
Why?
| | Carbon Radioisotopes | 1 | 2006 | 29 | 0.020 |
Why?
| | Cytokines | 1 | 2014 | 2067 | 0.010 |
Why?
| | Permeability | 1 | 2006 | 169 | 0.010 |
Why?
| | Amniotic Fluid | 1 | 2006 | 79 | 0.010 |
Why?
| | Protons | 1 | 2006 | 96 | 0.010 |
Why?
| | Muscle Proteins | 1 | 2006 | 242 | 0.010 |
Why?
| | Ultrasonography, Prenatal | 1 | 2006 | 295 | 0.010 |
Why?
| | Aged | 1 | 2024 | 26153 | 0.010 |
Why?
| | Phenotype | 1 | 2005 | 3155 | 0.010 |
Why?
|
|
Jansson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|